Showing results (51-60 of 2,365) with videos related to
Sort By:
Pageof 237
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1997
Enhancement of natural killer cell cytotoxicity by the human herpesvirus-7 via IL-15 inductionB N Atedzoe, A Ahmad, J MenezesInfection and Immunity|October 1, 1982
Cytotoxic effector cells from infectious mononucleosis patients in the acute phase do not specifically kill Epstein-Barr virus genome-carrying lymphoid cell linesP C Patel, G Dorval, J MenezesInternational Journal of Cancer|October 2, 2003
Physical activity and risk of renal cell carcinomaRavi J Menezes, George Tomlinson, Nancy KreigerExperimental Biology|January 1, 1985
Synthesis and release of plasminogen activator by lymphoid cell lines of malignant origin and its effect on lymphocyte cytotoxicityS K Sundar, J Bergeron, J MenezesInternational Journal of Cancer|June 19, 1991
Establishment and characterization of Epstein-Barr virus gp350-expressing transfected human lymphoid (Raji) cell clonesM Khyatti, P C Patel, J MenezesClinical and Experimental Immunology|June 1, 1984
Purified plasminogen activating factor produced by malignant lymphoid cells abrogates lymphocyte cytotoxicityS K Sundar, J Bergeron, J MenezesJournal of Molecular Biology|May 10, 2000
Binding of the Epstein-Barr virus major envelope glycoprotein gp350 results in the upregulation of the TNF-alpha gene expression in monocytic cells via NF-kappaB involving PKC, PI3-K and tyrosine kinasesM D'Addario, A Ahmad, A Morgan, et al.International Journal of Cancer|July 15, 1999
Elevated serum levels of transforming growth factor beta1 in Epstein-Barr virus-associated nasopharyngeal carcinoma patientsJ Xu, J Menezes, U Prasad, et al.Immunology|June 1, 1996
Effect of adoptive transfer of CD4, CD8 and B cells on recovery from MHV3-induced immunodeficienciesL Lamontagne, P Jolicoeur, D Decarie, et al.Intervirology|January 1, 1974
Infection of EBV-genome-negative and -positive human lymphoblastoid cell lines with biologically different preparations of EBVG Klein, B Sugden, W Leibold, et al.Pageof 237